Patents by Inventor Hiroshi Ueyama

Hiroshi Ueyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230359100
    Abstract: A light beam direction control element includes a light beam direction controller and a controller. The light beam direction controller includes light transmitting regions sandwiched between a first light transmissive substrate and a second light transmissive substrate, light absorbing regions located between light transmitting regions, a light transmissive dispersion medium sealingly contained in the light absorbing regions, and electrophoretic particles dispersed in the light transmissive dispersion medium.
    Type: Application
    Filed: May 4, 2023
    Publication date: November 9, 2023
    Applicant: TIANMA JAPAN, LTD.
    Inventor: Hiroshi UEYAMA
  • Publication number: 20180027064
    Abstract: A method includes: acquiring a coordinate region from a client terminal; if region information or a load on a computer or on a communication line between the computer and a client terminal satisfies a predetermined condition, performing a statistical process on a piece of sample data included in the coordinate region among a plurality of pieces of sample data in which coordinate positions and information related to the coordinate positions are associated with each other, transmitting the piece of sample data to the client terminal; and if the region information or the load on the computer or the communication line does not satisfy a predetermined condition, transmitting the piece of sample data included in the coordinate region to the client terminal.
    Type: Application
    Filed: August 15, 2017
    Publication date: January 25, 2018
    Inventors: Kazuhisa SHIBAYAMA, Yuji SOGA, Yusuke KATO, Hiroshi UEYAMA
  • Patent number: 9018354
    Abstract: An objective of the present invention is to provide methods of producing human collagen molecules that are easy to isolate and purify and that have a structure substantially equivalent to that of a natural collagen molecule, wherein host cells that are transduced with a collagen gene synthesize large amounts of human collagen protein derived from a gene introduced into a high exogenous gene expression vector. Another objective of the present invention is to provide collagen molecules produced by the production methods. The present inventors discovered that a large amount of human collagen hardly contaminated with host cell-derived collagen could be produced, by selecting from various mammalian cells a host cell that has low collagen expression and introducing a collagen gene construct into a vector capable of high exogenous gene expression.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: April 28, 2015
    Assignees: Fuso Pharmaceutical Industries, Ltd., Osaka Prefectural Government
    Inventors: Tetsuo Kase, Akio Kimura, Hiroshi Ueyama, Mizuki Nishihara, Yoko Kisaki, Aya Keshi
  • Publication number: 20120172577
    Abstract: An objective of the present invention is to provide methods of producing human collagen molecules that are easy to isolate and purify and that have a structure substantially equivalent to that of a natural collagen molecule, wherein host cells that are transduced with a collagen gene synthesize large amounts of human collagen protein derived from a gene introduced into a high exogenous gene expression vector. Another objective of the present invention is to provide collagen molecules produced by the production methods. The present inventors discovered that a large amount of human collagen hardly contaminated with host cell-derived collagen could be produced, by selecting from various mammalian cells a host cell that has low collagen expression and introducing a collagen gene construct into a vector capable of high exogenous gene expression.
    Type: Application
    Filed: March 31, 2006
    Publication date: July 5, 2012
    Inventors: Tetsuo Kase, Akio Kimura, Hiroshi Kisaki, Yoko Kisaki, Hiroyuki Keshi, Aya Keshi, Hiroshi Ueyama, Mizuki Nishihara
  • Patent number: 7193678
    Abstract: A liquid crystal display device includes an array substrate having a plurality of first seal frames each forming a panel area to become a display portion and a second seal frame containing these seal frames thereinside and being of a completely closed shape as a whole outside these first seal frames. The liquid crystal display device of the invention has a structure in which the whole inside of the second seal frame including the insides of the first seal frames of the array substrate is filled with liquid crystal by a liquid crystal dripping method and thereafter the color filter substrate is stuck on the array substrate. This display makes it possible to manufacture a liquid crystal display device of an aggregate liquid crystal display panel structure improved in uniformity of gap between both substrates.
    Type: Grant
    Filed: September 24, 2004
    Date of Patent: March 20, 2007
    Assignee: NEC LCD Technologies, Ltd.
    Inventor: Hiroshi Ueyama
  • Publication number: 20070059687
    Abstract: A digested phagocyte prepared by contacting in vitro a phagocyte with a foreign microorganism and isolating the phagocyte so contacted; a process for producing the same; and a process and a kit in which these are utilized are disclosed. An experimental model, which enables in vitro evaluation of a phagocytotic function of phagocytes, is provided.
    Type: Application
    Filed: May 27, 2002
    Publication date: March 15, 2007
    Inventors: Tsuneya Ohno, Akio Matsuhisa, Hiroyuki Keshi, Kanako Abe, Norihiko Sugimoto, Hiroshi Ueyama, Soji Eda, Hirotsugu Uehara, Takahisa Iwami, Seiji Yamamoto, Hiromasa Araki
  • Publication number: 20050099574
    Abstract: The invention aims at improving the uniformity in gap between an array substrate and a color filter substrate of a liquid crystal display device to be manufactured by a multi-panel forming process filling liquid crystal by a liquid crystal dripping method. A liquid crystal display device of the invention comprises an array substrate having a plurality of first seal frames each forming a panel area to become a display portion and a second seal frame containing these seal frames thereinside and being of a completely closed shape as a whole outside these first seal frames. The liquid crystal display device of the invention has a structure in which the whole inside of the second seal frame including the insides of the first seal frames of the array substrate is filled with liquid crystal by a liquid crystal dripping method and thereafter the color filter substrate is stuck on the array substrate.
    Type: Application
    Filed: September 24, 2004
    Publication date: May 12, 2005
    Applicant: NEC LCD Technologies, Ltd.
    Inventor: Hiroshi Ueyama
  • Patent number: 6660852
    Abstract: A probe derived from bacteria of pneumonia, containing fragments of DNA which streptococcus pneumoniae essentially possesses, and useful for detecting and identifying causative bacteria of pneumonia is obtained by completely digesting the DNA with a restriction endonuclease PstI, followed by cloning into a suitable vector.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: December 9, 2003
    Assignee: Fuso Pharmaceutical Industries, Ltd.
    Inventors: Hiroyuki Keshi, Soji Eda, Hirotsugu Uehara, Hiroshi Ueyama, Akio Matsuhisa
  • Patent number: 6265568
    Abstract: The DNA from the bacteria Bactereoides fragilis is extracted, then completely digested with restriction enzyme HindIII, followed by cloning into a suitable vector to select a probe comprising DNA which is essentially contained in Bacteroides fragilis, then the sequence of the probe is elucidated.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: July 24, 2001
    Assignee: Fuso Pharmaceutical Industries, Ltd.
    Inventors: Hiroshi Ueyama, Kanako Abe, Hiroyuki Keshi, Akio Matsuhisa
  • Patent number: 6245906
    Abstract: The DNA from the bacteria Streptococcus pyogenes is extracted, then completely digested with restriction enzyme HindIII, followed by cloning into a suitable vector to select a probe comprising DNA which is essentially contained in Streptococcus pyogenes, then the sequence of the probe is elucidated.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: June 12, 2001
    Assignee: Fuso Pharmaceutical Industries, Ltd.
    Inventors: Hiroshi Ueyama, Kanako Abe, Hiroyuki Keshi, Akio Matsuhisa
  • Patent number: 6225453
    Abstract: The DNA from the bacteria Klebsiella pneumoniae is extracted, then completely digested with restriction enzyme Hind III, followed by cloning into a suitable vector to select a probe comprising DNA which is essentially contained in Klebsiella pneumoniae, then the sequence of the probe is elucidated.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: May 1, 2001
    Assignee: FUSO Pharmaceutical Industries, Ltd.
    Inventors: Hiroshi Ueyama, Kanako Abe, Hiroyuki Keshi, Akio Matsuhisa